Loading…

Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome

While neurofibromatosis type 1 (NF1) and Noonan syndrome (NS) are clinically distinct genetic syndromes, they have overlapping features because they are caused by pathogenic variants in genes encoding molecules within the Ras‐mitogen‐activated protein kinase signaling pathway. Increased risk for emo...

Full description

Saved in:
Bibliographic Details
Published in:American journal of medical genetics. Part A 2019-12, Vol.179 (12), p.2433-2446
Main Authors: McNeill, Alana M., Hudock, Rebekah L., Foy, Allison M. H., Shanley, Ryan, Semrud‐Clikeman, Margaret, Pierpont, Mary Ella, Berry, Susan A., Sommer, Katherine, Moertel, Christopher L., Pierpont, Elizabeth I.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3641-d0a211c76235ed5b0ec9252ae026f1aefaa5a26efce7a11705664906d08824ab3
cites cdi_FETCH-LOGICAL-c3641-d0a211c76235ed5b0ec9252ae026f1aefaa5a26efce7a11705664906d08824ab3
container_end_page 2446
container_issue 12
container_start_page 2433
container_title American journal of medical genetics. Part A
container_volume 179
creator McNeill, Alana M.
Hudock, Rebekah L.
Foy, Allison M. H.
Shanley, Ryan
Semrud‐Clikeman, Margaret
Pierpont, Mary Ella
Berry, Susan A.
Sommer, Katherine
Moertel, Christopher L.
Pierpont, Elizabeth I.
description While neurofibromatosis type 1 (NF1) and Noonan syndrome (NS) are clinically distinct genetic syndromes, they have overlapping features because they are caused by pathogenic variants in genes encoding molecules within the Ras‐mitogen‐activated protein kinase signaling pathway. Increased risk for emotional and behavioral challenges has been reported in both children and adults with these syndromes. The current study examined parent‐report and self‐report measures of emotional functioning among children with NF1 and NS as compared to their unaffected siblings. Parents and children with NS (n = 39), NF1 (n = 39), and their siblings without a genetic condition (n = 32) completed well‐validated clinical symptom rating scales. Results from parent questionnaires indicated greater symptomatology on scales measuring internalizing behaviors and symptoms of attention deficit hyperactivity disorder (ADHD) in both syndrome groups as compared with unaffected children. Frequency and severity of emotional and behavioral symptoms were remarkably similar across the two clinical groups. Symptoms of depression and anxiety were higher in children who were also rated as meeting symptom criteria for ADHD. While self‐report ratings by children generally correlated with parent ratings, symptom severity was less pronounced. Among unaffected siblings, parent ratings indicated higher than expected levels of anxiety. Study findings may assist with guiding family‐based interventions to address emotional challenges.
doi_str_mv 10.1002/ajmg.a.61361
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2299457688</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2313244136</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3641-d0a211c76235ed5b0ec9252ae026f1aefaa5a26efce7a11705664906d08824ab3</originalsourceid><addsrcrecordid>eNp9kD1PwzAQQC0E4ntjRpZYGGjxR-wkY4WggAosdLauyQVcJXGxE1X997i0dGBgsU_y05PvEXLB2ZAzJm5h3nwMYai51HyPHHOlxCDJpNzfzUIdkZMQ5oxJplJ9SI4kV1pneXpMpveN66xroaZV3xbr0bYfFBoXz-LT1qXHli5t90lb7L2r7My7BjoXbKDdaoGUU-fpq4uKloZVW8ZnPCMHFdQBz7f3KZk-3L_fPQ4mb-Onu9FkUEid8EHJQHBepFpIhaWaMSxyoQQgE7rigBWAAqGxKjAFzlMWf53kTJcsy0QCM3lKrjfehXdfPYbONDYUWNfQouuDESLPk7hylkX06g86d72Pe0dKcimSJAaM1M2GKrwLwWNlFt424FeGM7PObda5DZif3BG_3Er7WYPlDv7tG4FkAyxtjat_ZWb0_DIebbzfANeL_w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2313244136</pqid></control><display><type>article</type><title>Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>McNeill, Alana M. ; Hudock, Rebekah L. ; Foy, Allison M. H. ; Shanley, Ryan ; Semrud‐Clikeman, Margaret ; Pierpont, Mary Ella ; Berry, Susan A. ; Sommer, Katherine ; Moertel, Christopher L. ; Pierpont, Elizabeth I.</creator><creatorcontrib>McNeill, Alana M. ; Hudock, Rebekah L. ; Foy, Allison M. H. ; Shanley, Ryan ; Semrud‐Clikeman, Margaret ; Pierpont, Mary Ella ; Berry, Susan A. ; Sommer, Katherine ; Moertel, Christopher L. ; Pierpont, Elizabeth I.</creatorcontrib><description>While neurofibromatosis type 1 (NF1) and Noonan syndrome (NS) are clinically distinct genetic syndromes, they have overlapping features because they are caused by pathogenic variants in genes encoding molecules within the Ras‐mitogen‐activated protein kinase signaling pathway. Increased risk for emotional and behavioral challenges has been reported in both children and adults with these syndromes. The current study examined parent‐report and self‐report measures of emotional functioning among children with NF1 and NS as compared to their unaffected siblings. Parents and children with NS (n = 39), NF1 (n = 39), and their siblings without a genetic condition (n = 32) completed well‐validated clinical symptom rating scales. Results from parent questionnaires indicated greater symptomatology on scales measuring internalizing behaviors and symptoms of attention deficit hyperactivity disorder (ADHD) in both syndrome groups as compared with unaffected children. Frequency and severity of emotional and behavioral symptoms were remarkably similar across the two clinical groups. Symptoms of depression and anxiety were higher in children who were also rated as meeting symptom criteria for ADHD. While self‐report ratings by children generally correlated with parent ratings, symptom severity was less pronounced. Among unaffected siblings, parent ratings indicated higher than expected levels of anxiety. Study findings may assist with guiding family‐based interventions to address emotional challenges.</description><identifier>ISSN: 1552-4825</identifier><identifier>EISSN: 1552-4833</identifier><identifier>DOI: 10.1002/ajmg.a.61361</identifier><identifier>PMID: 31566897</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Anxiety ; Attention deficit hyperactivity disorder ; Children ; depression ; Emotional behavior ; emotional function ; Genetic disorders ; Kinases ; Neurofibromatosis ; neurofibromatosis type 1 ; Neurological disorders ; Noonan syndrome ; Noonan's syndrome ; Protein kinase ; RASopathies ; Recklinghausen's disease ; Siblings ; Signal transduction ; Tumors</subject><ispartof>American journal of medical genetics. Part A, 2019-12, Vol.179 (12), p.2433-2446</ispartof><rights>2019 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3641-d0a211c76235ed5b0ec9252ae026f1aefaa5a26efce7a11705664906d08824ab3</citedby><cites>FETCH-LOGICAL-c3641-d0a211c76235ed5b0ec9252ae026f1aefaa5a26efce7a11705664906d08824ab3</cites><orcidid>0000-0001-7555-8613 ; 0000-0002-9943-5236</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31566897$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McNeill, Alana M.</creatorcontrib><creatorcontrib>Hudock, Rebekah L.</creatorcontrib><creatorcontrib>Foy, Allison M. H.</creatorcontrib><creatorcontrib>Shanley, Ryan</creatorcontrib><creatorcontrib>Semrud‐Clikeman, Margaret</creatorcontrib><creatorcontrib>Pierpont, Mary Ella</creatorcontrib><creatorcontrib>Berry, Susan A.</creatorcontrib><creatorcontrib>Sommer, Katherine</creatorcontrib><creatorcontrib>Moertel, Christopher L.</creatorcontrib><creatorcontrib>Pierpont, Elizabeth I.</creatorcontrib><title>Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome</title><title>American journal of medical genetics. Part A</title><addtitle>Am J Med Genet A</addtitle><description>While neurofibromatosis type 1 (NF1) and Noonan syndrome (NS) are clinically distinct genetic syndromes, they have overlapping features because they are caused by pathogenic variants in genes encoding molecules within the Ras‐mitogen‐activated protein kinase signaling pathway. Increased risk for emotional and behavioral challenges has been reported in both children and adults with these syndromes. The current study examined parent‐report and self‐report measures of emotional functioning among children with NF1 and NS as compared to their unaffected siblings. Parents and children with NS (n = 39), NF1 (n = 39), and their siblings without a genetic condition (n = 32) completed well‐validated clinical symptom rating scales. Results from parent questionnaires indicated greater symptomatology on scales measuring internalizing behaviors and symptoms of attention deficit hyperactivity disorder (ADHD) in both syndrome groups as compared with unaffected children. Frequency and severity of emotional and behavioral symptoms were remarkably similar across the two clinical groups. Symptoms of depression and anxiety were higher in children who were also rated as meeting symptom criteria for ADHD. While self‐report ratings by children generally correlated with parent ratings, symptom severity was less pronounced. Among unaffected siblings, parent ratings indicated higher than expected levels of anxiety. Study findings may assist with guiding family‐based interventions to address emotional challenges.</description><subject>Anxiety</subject><subject>Attention deficit hyperactivity disorder</subject><subject>Children</subject><subject>depression</subject><subject>Emotional behavior</subject><subject>emotional function</subject><subject>Genetic disorders</subject><subject>Kinases</subject><subject>Neurofibromatosis</subject><subject>neurofibromatosis type 1</subject><subject>Neurological disorders</subject><subject>Noonan syndrome</subject><subject>Noonan's syndrome</subject><subject>Protein kinase</subject><subject>RASopathies</subject><subject>Recklinghausen's disease</subject><subject>Siblings</subject><subject>Signal transduction</subject><subject>Tumors</subject><issn>1552-4825</issn><issn>1552-4833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PwzAQQC0E4ntjRpZYGGjxR-wkY4WggAosdLauyQVcJXGxE1X997i0dGBgsU_y05PvEXLB2ZAzJm5h3nwMYai51HyPHHOlxCDJpNzfzUIdkZMQ5oxJplJ9SI4kV1pneXpMpveN66xroaZV3xbr0bYfFBoXz-LT1qXHli5t90lb7L2r7My7BjoXbKDdaoGUU-fpq4uKloZVW8ZnPCMHFdQBz7f3KZk-3L_fPQ4mb-Onu9FkUEid8EHJQHBepFpIhaWaMSxyoQQgE7rigBWAAqGxKjAFzlMWf53kTJcsy0QCM3lKrjfehXdfPYbONDYUWNfQouuDESLPk7hylkX06g86d72Pe0dKcimSJAaM1M2GKrwLwWNlFt424FeGM7PObda5DZif3BG_3Er7WYPlDv7tG4FkAyxtjat_ZWb0_DIebbzfANeL_w</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>McNeill, Alana M.</creator><creator>Hudock, Rebekah L.</creator><creator>Foy, Allison M. H.</creator><creator>Shanley, Ryan</creator><creator>Semrud‐Clikeman, Margaret</creator><creator>Pierpont, Mary Ella</creator><creator>Berry, Susan A.</creator><creator>Sommer, Katherine</creator><creator>Moertel, Christopher L.</creator><creator>Pierpont, Elizabeth I.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7555-8613</orcidid><orcidid>https://orcid.org/0000-0002-9943-5236</orcidid></search><sort><creationdate>201912</creationdate><title>Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome</title><author>McNeill, Alana M. ; Hudock, Rebekah L. ; Foy, Allison M. H. ; Shanley, Ryan ; Semrud‐Clikeman, Margaret ; Pierpont, Mary Ella ; Berry, Susan A. ; Sommer, Katherine ; Moertel, Christopher L. ; Pierpont, Elizabeth I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3641-d0a211c76235ed5b0ec9252ae026f1aefaa5a26efce7a11705664906d08824ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Anxiety</topic><topic>Attention deficit hyperactivity disorder</topic><topic>Children</topic><topic>depression</topic><topic>Emotional behavior</topic><topic>emotional function</topic><topic>Genetic disorders</topic><topic>Kinases</topic><topic>Neurofibromatosis</topic><topic>neurofibromatosis type 1</topic><topic>Neurological disorders</topic><topic>Noonan syndrome</topic><topic>Noonan's syndrome</topic><topic>Protein kinase</topic><topic>RASopathies</topic><topic>Recklinghausen's disease</topic><topic>Siblings</topic><topic>Signal transduction</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McNeill, Alana M.</creatorcontrib><creatorcontrib>Hudock, Rebekah L.</creatorcontrib><creatorcontrib>Foy, Allison M. H.</creatorcontrib><creatorcontrib>Shanley, Ryan</creatorcontrib><creatorcontrib>Semrud‐Clikeman, Margaret</creatorcontrib><creatorcontrib>Pierpont, Mary Ella</creatorcontrib><creatorcontrib>Berry, Susan A.</creatorcontrib><creatorcontrib>Sommer, Katherine</creatorcontrib><creatorcontrib>Moertel, Christopher L.</creatorcontrib><creatorcontrib>Pierpont, Elizabeth I.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of medical genetics. Part A</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McNeill, Alana M.</au><au>Hudock, Rebekah L.</au><au>Foy, Allison M. H.</au><au>Shanley, Ryan</au><au>Semrud‐Clikeman, Margaret</au><au>Pierpont, Mary Ella</au><au>Berry, Susan A.</au><au>Sommer, Katherine</au><au>Moertel, Christopher L.</au><au>Pierpont, Elizabeth I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome</atitle><jtitle>American journal of medical genetics. Part A</jtitle><addtitle>Am J Med Genet A</addtitle><date>2019-12</date><risdate>2019</risdate><volume>179</volume><issue>12</issue><spage>2433</spage><epage>2446</epage><pages>2433-2446</pages><issn>1552-4825</issn><eissn>1552-4833</eissn><abstract>While neurofibromatosis type 1 (NF1) and Noonan syndrome (NS) are clinically distinct genetic syndromes, they have overlapping features because they are caused by pathogenic variants in genes encoding molecules within the Ras‐mitogen‐activated protein kinase signaling pathway. Increased risk for emotional and behavioral challenges has been reported in both children and adults with these syndromes. The current study examined parent‐report and self‐report measures of emotional functioning among children with NF1 and NS as compared to their unaffected siblings. Parents and children with NS (n = 39), NF1 (n = 39), and their siblings without a genetic condition (n = 32) completed well‐validated clinical symptom rating scales. Results from parent questionnaires indicated greater symptomatology on scales measuring internalizing behaviors and symptoms of attention deficit hyperactivity disorder (ADHD) in both syndrome groups as compared with unaffected children. Frequency and severity of emotional and behavioral symptoms were remarkably similar across the two clinical groups. Symptoms of depression and anxiety were higher in children who were also rated as meeting symptom criteria for ADHD. While self‐report ratings by children generally correlated with parent ratings, symptom severity was less pronounced. Among unaffected siblings, parent ratings indicated higher than expected levels of anxiety. Study findings may assist with guiding family‐based interventions to address emotional challenges.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>31566897</pmid><doi>10.1002/ajmg.a.61361</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0001-7555-8613</orcidid><orcidid>https://orcid.org/0000-0002-9943-5236</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1552-4825
ispartof American journal of medical genetics. Part A, 2019-12, Vol.179 (12), p.2433-2446
issn 1552-4825
1552-4833
language eng
recordid cdi_proquest_miscellaneous_2299457688
source Wiley-Blackwell Read & Publish Collection
subjects Anxiety
Attention deficit hyperactivity disorder
Children
depression
Emotional behavior
emotional function
Genetic disorders
Kinases
Neurofibromatosis
neurofibromatosis type 1
Neurological disorders
Noonan syndrome
Noonan's syndrome
Protein kinase
RASopathies
Recklinghausen's disease
Siblings
Signal transduction
Tumors
title Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A21%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emotional%20functioning%20among%20children%20with%20neurofibromatosis%20type%201%20or%20Noonan%20syndrome&rft.jtitle=American%20journal%20of%20medical%20genetics.%20Part%20A&rft.au=McNeill,%20Alana%20M.&rft.date=2019-12&rft.volume=179&rft.issue=12&rft.spage=2433&rft.epage=2446&rft.pages=2433-2446&rft.issn=1552-4825&rft.eissn=1552-4833&rft_id=info:doi/10.1002/ajmg.a.61361&rft_dat=%3Cproquest_cross%3E2313244136%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3641-d0a211c76235ed5b0ec9252ae026f1aefaa5a26efce7a11705664906d08824ab3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2313244136&rft_id=info:pmid/31566897&rfr_iscdi=true